Cargando…

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

BACKGROUND: Recently studies had showed that the amygdala may take part in the cognitive impairment in schizophrenia (SC). However, the mechanism is still unclear, so we explored the relationship between the amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huagui, Ye, Haibiao, Li, Zhijian, Li, Xuesong, Huang, Wei, Yang, Yu, Xie, Guojun, Xu, Caixia, Li, Xiaoling, Liang, Wenting, Jing, Huan, Zhang, Chunguo, Tang, Chaohua, Liang, Jiaquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074687/
https://www.ncbi.nlm.nih.gov/pubmed/37020192
http://dx.doi.org/10.1186/s12888-023-04728-6
_version_ 1785019789380419584
author Guo, Huagui
Ye, Haibiao
Li, Zhijian
Li, Xuesong
Huang, Wei
Yang, Yu
Xie, Guojun
Xu, Caixia
Li, Xiaoling
Liang, Wenting
Jing, Huan
Zhang, Chunguo
Tang, Chaohua
Liang, Jiaquan
author_facet Guo, Huagui
Ye, Haibiao
Li, Zhijian
Li, Xuesong
Huang, Wei
Yang, Yu
Xie, Guojun
Xu, Caixia
Li, Xiaoling
Liang, Wenting
Jing, Huan
Zhang, Chunguo
Tang, Chaohua
Liang, Jiaquan
author_sort Guo, Huagui
collection PubMed
description BACKGROUND: Recently studies had showed that the amygdala may take part in the cognitive impairment in schizophrenia (SC). However, the mechanism is still unclear, so we explored the relationship between the amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function, to provide a reference for the follow-up study. METHODS: We collected 59 drug-naïve SCs and 46 healthy controls (HCs) from the Third People’s Hospital of Foshan. The rsMRI technique and automatic segmentation tool were used to extract the volume and functional indicators of the SC’s amygdala. The Positive and Negative Syndrome Scale (PANSS) was used to assess the severity of the disease, and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used to assess cognitive function. Pearson correlation analysis was used to compare the relationship between the structural and functional indicators of the amygdala and PANSS and RBANS. RESULTS: (1) There was no significant difference between SC and HC in age, gender and years of education. Compared with HC, the PANSS score of SC increased and the RBANS score decreased significantly. Meanwhile, the left amygdala volume decreased (t=-3.675, p < 0.001), and the Fractional amplitude of low-frequency fluctuations (FALFF) values of bilateral amygdala increased (t(L)=3.916, p < 0.001; t(R)=3.131, p = 0.002). (2) The volumes of the left amygdala were negatively correlated with the PANSS score (r(L)=-0.243, p = 0.039). While the FALFF values of the bilateral amygdala were positively correlated with the PANSS score (r(L)=0.257, p = 0.026; r(R)=0.259, p = 0.026). Bilateral amygdala volumes and FALFF values were positively correlated (r(L)=0.445, p < 0.001; r(R)=0.326, p = 0.006) and negatively correlated with RBANS score (r(L)=-0.284, p = 0.014; r(R)=-0.272, p = 0.020), respectively. CONCLUSION: The abnormal volume and function of the amygdala play important roles in the disease process of SC, and are closely related to cognitive impairment.
format Online
Article
Text
id pubmed-10074687
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100746872023-04-06 Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia Guo, Huagui Ye, Haibiao Li, Zhijian Li, Xuesong Huang, Wei Yang, Yu Xie, Guojun Xu, Caixia Li, Xiaoling Liang, Wenting Jing, Huan Zhang, Chunguo Tang, Chaohua Liang, Jiaquan BMC Psychiatry Research BACKGROUND: Recently studies had showed that the amygdala may take part in the cognitive impairment in schizophrenia (SC). However, the mechanism is still unclear, so we explored the relationship between the amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function, to provide a reference for the follow-up study. METHODS: We collected 59 drug-naïve SCs and 46 healthy controls (HCs) from the Third People’s Hospital of Foshan. The rsMRI technique and automatic segmentation tool were used to extract the volume and functional indicators of the SC’s amygdala. The Positive and Negative Syndrome Scale (PANSS) was used to assess the severity of the disease, and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was used to assess cognitive function. Pearson correlation analysis was used to compare the relationship between the structural and functional indicators of the amygdala and PANSS and RBANS. RESULTS: (1) There was no significant difference between SC and HC in age, gender and years of education. Compared with HC, the PANSS score of SC increased and the RBANS score decreased significantly. Meanwhile, the left amygdala volume decreased (t=-3.675, p < 0.001), and the Fractional amplitude of low-frequency fluctuations (FALFF) values of bilateral amygdala increased (t(L)=3.916, p < 0.001; t(R)=3.131, p = 0.002). (2) The volumes of the left amygdala were negatively correlated with the PANSS score (r(L)=-0.243, p = 0.039). While the FALFF values of the bilateral amygdala were positively correlated with the PANSS score (r(L)=0.257, p = 0.026; r(R)=0.259, p = 0.026). Bilateral amygdala volumes and FALFF values were positively correlated (r(L)=0.445, p < 0.001; r(R)=0.326, p = 0.006) and negatively correlated with RBANS score (r(L)=-0.284, p = 0.014; r(R)=-0.272, p = 0.020), respectively. CONCLUSION: The abnormal volume and function of the amygdala play important roles in the disease process of SC, and are closely related to cognitive impairment. BioMed Central 2023-04-05 /pmc/articles/PMC10074687/ /pubmed/37020192 http://dx.doi.org/10.1186/s12888-023-04728-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guo, Huagui
Ye, Haibiao
Li, Zhijian
Li, Xuesong
Huang, Wei
Yang, Yu
Xie, Guojun
Xu, Caixia
Li, Xiaoling
Liang, Wenting
Jing, Huan
Zhang, Chunguo
Tang, Chaohua
Liang, Jiaquan
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title_full Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title_fullStr Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title_full_unstemmed Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title_short Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
title_sort amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074687/
https://www.ncbi.nlm.nih.gov/pubmed/37020192
http://dx.doi.org/10.1186/s12888-023-04728-6
work_keys_str_mv AT guohuagui amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT yehaibiao amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT lizhijian amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT lixuesong amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT huangwei amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT yangyu amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT xieguojun amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT xucaixia amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT lixiaoling amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT liangwenting amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT jinghuan amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT zhangchunguo amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT tangchaohua amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia
AT liangjiaquan amygdalasignalabnormalityandcognitiveimpairmentindrugnaiveschizophrenia